Artiva Biotherapeutics director Elizabeth Hougen resigns
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Artiva Biotherapeutics, Inc. (ARTV) said Elizabeth Hougen resigned as a Class III director on November 11, 2026, effective immediately. The company said her resignation was not the result of a disagreement over its operations, policies or practices.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who resigned from Artiva Biotherapeutics’ board?
Elizabeth Hougen resigned as a Class III director effective November 11, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.